| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023666 |
| Receipt No. | R000027260 |
| Official scientific title of the study | Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study- |
| Date of disclosure of the study information | 2016/08/18 |
| Last modified on | 2016/10/14 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study- | |
| Title of the study (Brief title) | Suppressive effect of combination of test food on the postprandial triglyceride level | |
| Region |
|
|
| Condition | ||
| Condition | None | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of test food on the postprandial blood triglyceride level of subjects. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Area under the curve for serum triglyceride level |
| Key secondary outcomes | Fasting serum triglyceride level, serum triglyceride levels of 2, 3, 4, and 6 hours after high fate meal ingestion, Remnant-like particle cholesterol |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food, and then ingestion of placebo after wash out period. | |
| Interventions/Control_2 | Intake of placebo, and then ingestion of test food after wash out period. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Males and females 20 to 64 years of age
2) Subjects whose fasting serum triglyceride levels are less than 200 mg/dL. |
|||
| Key exclusion criteria | 1) Subjects who routinely use medicine related to lipid metabolism.
2) Subjects who routinely use medicine, supplements, FOSHU, and/or health food which affect to result of the study. 3) Subjects who have allergy to test food and/or high fat meal and have extreme lactose intolerance or diarrhea. 4) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. 5) Heavy user of alcohol or excessive smokers 6) Subjects who have under treatment of chronic disease and routinely uses a medicine. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Jyouji Kurokawa |
| Organization | Medical Corporation Shoureikan Sinsapporo seiryou Hospital |
| Division name | General Clinical Department |
| Address | 2-1-30, Atsubetsuhigashi4jo, Atsubetsu-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-898-2151 |
| j.kurokawa@shoureikan.jp | |
| Public contact | |
| Name of contact person | Masaya Tsubokawa |
| Organization | FANCL Corporation |
| Division name | Research Institute |
| Address | 12-13 Kamishinano, Totsuka-ku, Yokohama, Kanagawa, Japan |
| TEL | 045-820-3569 |
| Homepage URL | |
| tsubokawa_masaya@fancl.co.jp | |
| Sponsor | |
| Institute | FANCL Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Jpan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団翔嶺館新札幌聖陵ホスピタル |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027260 |